Treat to Target #5 – VFA

Treat to Target of NO NEW FRACTURES.  How do we find that target?  DXA >-2.5 is a start.  Fragility fractures increase new fracture risk.  FRAX adds many more risk factors to the...

Treat to Target #4 – TBS

Our goal is NO NEW FRACTURES.  Cancellous (spongy, like the ends of the drumstick) bone should be a strong latticework of struts called trabeculi.  Clinical Osteoporosis, an increased fracture risk,...

Treat to Target #3 – FRAX

Our Target is NO NEW FRACTURES.  The original goal by DXA was a  T-score of -2.4 or better.  But age is a huge factor in actual fracture risk.  The fracture risk...

Treat to Target # 2 – Fragility Fracture

Treat to Target means aiming for NO NEW FRACTURES.  As discussed last time, the original target was to maintain Bone Mineral Density (BMD) at the level first tested.  25 years...

A New Anabolic – Tymlos

The FDA approved Tymlos (Abaloparatide) in June for use in women diagnosed with osteoporosis.  Unfortunately most patients are unlikely to obtain insurance coverage for Tymlos until January or February 2018. Tymlos...

Treat to Target #1 – Which Target?

Treat to Target has been standard for chronic diseases like high blood pressure and diabetes for decades.  These are chronic diseases, more common as we get older, that we can control...

The Bone Health Guidelines are Changing

University of Wisconsin hosts biennially the Bare Bones of Osteoporosis Care Symposium.  This year the Wisconsin Bone Club followed the symposium. Felicia Cosman, MD from Helen Hayes in New York was the guest...

Remember

As we enter Memorial Day Weekend, let us remember those who have served in times of war, declared and undeclared. Evil exists in our world.  Those who survived the fight against the...

National Osteoporosis Prevention Month

May is National Osteoporosis Month.  That should be National Osteoporosis Prevention Month.  Or perhaps National Bone Health Optimization Month. Click on the helpful link to National Osteoporosis Foundation to learn...

“Treat to Target” and “Use VFA” in 2017

Clinical Osteoporosis 2017, NOF and ISCD joint meeting had a different emphasis this year.  Fracture Risk, rather than Bone Mineral Density (BMD) is now the key metric.  Several speakers emphasizd...